Filtered By:
Source: Journal of Clinical Oncology
Procedure: MRI Scan
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
First-in-Human Phase I Study of the Liposomal RNA Interference Therapeutic Atu027 in Patients With Advanced Solid Tumors Phase I and Clinical Pharmacology
Conclusion
Atu027 was safe in patients with advanced solid tumors, with 41% of patients having stable disease for at least 8 weeks. In view of these results, further clinical trials have been initiated, and sFLT1 will be investigated as a potential biomarker.
Source: Journal of Clinical Oncology - December 17, 2014 Category: Cancer & Oncology Authors: Schultheis, Strumberg, Santel, Vank, Gebhardt, Keil, Lange, Giese, Kaufmann, Khan, Drevs Tags: Clinical Trials, Phase I and Clinical Pharmacology, Phase I and Clinical Pharmacology Source Type: research
